BTW
Boston Trust Walden Portfolio holdings
AUM
$14B
This Quarter Return
-2.49%
1 Year Return
+12.58%
3 Year Return
+52.97%
5 Year Return
+115.22%
10 Year Return
+284.47%
AUM
$6.48B
AUM Growth
+$6.48B
(-5.9%)
Cap. Flow
-$158M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
11.84%
Holding
348
New
13
Increased
75
Reduced
210
Closed
13
Top Buys
| 1 |
ONE Gas
OGS
|
$38.9M |
| 2 |
Cheesecake Factory
CAKE
|
$34.2M |
| 3 |
Visa
V
|
$24.5M |
| 4 |
Flowers Foods
FLO
|
$24.1M |
| 5 |
Artisan Partners
APAM
|
$22.6M |
Top Sells
| 1 |
Fortinet
FTNT
|
$41.3M |
| 2 |
Columbia Sportswear
COLM
|
$37.6M |
| 3 |
IBM
IBM
|
$31M |
| 4 |
VIVO
Meridian Bioscience Inc
VIVO
|
$25M |
| 5 |
LTM
LIFE TIME FITNESS INC
LTM
|
$24.9M |
Sector Composition
| 1 | Financials | 17.16% |
| 2 | Technology | 16.09% |
| 3 | Industrials | 13.66% |
| 4 | Healthcare | 11.16% |
| 5 | Consumer Discretionary | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Graco
GGG
$14.1B
| $630K | 0.01% | 8,625 +100 | +1% | +$7.3K |
|
302
iShares MSCI EAFE ETF
EFA
$66B
| $604K | 0.01% | 9,415 +152 | +2% | +$9.75K |
|
|
BBBY
303
DELISTED
Bed Bath & Beyond Inc
BBBY
| $600K | 0.01% | 9,110 | – | – |
|
|
CELG
304
DELISTED
Celgene Corp
CELG
| $550K | 0.01% | 5,800 | – | – |
|
305
VF Corp
VFC
$5.91B
| $541K | 0.01% | 8,200 | – | – |
|
306
Rockwell Automation
ROK
$38.6B
| $494K | 0.01% | 4,500 | – | – |
|
307
Amphenol
APH
$133B
| $489K | 0.01% | 4,900 | – | – |
|
308
Boeing
BA
$177B
| $479K | 0.01% | 3,760 -167 | -4% | -$21.3K |
|
309
Norfolk Southern
NSC
$62.8B
| $466K | 0.01% | 4,175 | – | – |
|
310
Adobe
ADBE
$151B
| $465K | 0.01% | 6,715 +310 | +5% | +$21.5K |
|
311
Moody's
MCO
$91.4B
| $456K | 0.01% | 4,830 | – | – |
|
312
CVS Health
CVS
$92.8B
| $446K | 0.01% | 5,600 | – | – |
|
|
DD
313
DELISTED
Du Pont De Nemours E I
DD
| $417K | 0.01% | 5,807 -175 | -3% | -$12.6K |
|
314
Vanguard Real Estate ETF
VNQ
$34.6B
| $415K | 0.01% | 5,775 +200 | +4% | +$14.4K |
|
315
Honeywell
HON
$139B
| $384K | 0.01% | 4,120 +16 | +0.4% | +$1.49K |
|
316
Thermo Fisher Scientific
TMO
$186B
| $376K | 0.01% | 3,092 +117 | +4% | +$14.2K |
|
317
C.H. Robinson
CHRW
$15.2B
| $373K | 0.01% | 5,625 | – | – |
|
|
PDCO
318
DELISTED
Patterson Companies, Inc.
PDCO
| $369K | 0.01% | 8,900 +950 | +12% | +$39.4K |
|
319
Idexx Laboratories
IDXX
$51.8B
| $368K | 0.01% | 3,125 | – | – |
|
320
Ingredion
INGR
$8.31B
| $367K | 0.01% | 4,840 | – | – |
|
321
Regeneron Pharmaceuticals
REGN
$61.5B
| $361K | 0.01% | 1,000 | – | – |
|
322
Southern Company
SO
$102B
| $349K | 0.01% | 8,000 +500 | +7% | +$21.8K |
|
323
Marsh & McLennan
MMC
$101B
| $345K | 0.01% | 6,600 | – | – |
|
324
WEC Energy
WEC
$34.3B
| $322K | 0.01% | 7,500 | – | – |
|
325
Bank of America
BAC
$376B
| $321K | 0.01% | 18,802 | – | – |
|